Prosecutors have asked permission to present evidence of a "prior bad act" by University of Pittsburgh researcher Robert Ferrante during his criminal trial in which he allegedly improperly tested a neurotoxin on a lab mouse.
Defense attorneys in a court filing on Wednesday called the move "speculative and ambiguous" and said it "would invite the jury to speculate as to its significance."
The document was filed in response to a Sept. 2 motion by the commonwealth notifying the court that it intended to pursue what what is known as 404(b) evidence during Mr. Ferrante's homicide trial for the death of his wife, Dr. Autumn Klein.
According to the defense filing, the prosecution wants to call a laboratory technician from the University of Pittsburgh named Molly Ann Lauver,who would testify that she worked for Mr. Ferrante for about two years, primarly with lab mice and the side effects of various drugs on them.
"[A]t one point during her work with defendant, Dr. Ferrante directed her to bring him one of the mice so that he could test the potency of 3-nitropropionic acid, a mitochondrial toxin," the defense said. "Ms. Lauver purportedly will testify that she brought a mouse to defendant and then was later summoned by Dr. Ferrante to retrieve the mouse's dead body."
According to the Pennsylvania law, evidence of a prior bad act is admissible for "proving motive, opportunity, intent, preparation, plan, knowledge, identity, absence of mistake, or lack of accident. In a criminal case this evidence is admissible only if the probative value of the evidence outweighs its potential for unfair prejudice.
In its response, the defense said that the prosecution alleges that Klein was killed with cyanide.
"Nowhere in this case does the commonwealth allege that defendant used 3-NP to poison Autumn Klein," the defense wrote. "In the voluminous discovery there is no such evidence of that. Thus, the relationship between any alleged impropriety involving a mouse and 3-NP to a wholly distinct incident allegedly involving cyanide and a human is speculative and ambiguous."
"Nowhere does the commonwealth state that it hypothesizes that defendant was testing 3-NP on a mouse for later use on his wife," the defense said.
Further, the defense argues that even if the testimony would be true, "it does not constitute a crime or wrongful act."
The response notes that Mr. Ferrante has done animal-based research for ALS, Huntington's disease and regenerative medicine, and that he has been a member of the Rodent Advisory Committee at the University of Pittsburgh Medical School.
The commonwealth's motion, according to the defense, said that the evidence would be probative "of the defendant's opportunity, intent, preparation, plan and knowledge in this case."





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.